|
|
Bristol-Myers Squibb Co.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
R&D turbulence at Bristol MyersAnyone has access to Endpoints premium subscription? The have this article "R&D turbulence at Bristol Myers now includes the end of a $650M alliance and the departure of a top research champion This morning biotech Dragonfly put out word that Bristol Myers Squibb has handed back all rights to its IL-12 clinical-stage drug after spending $650 million to advance it into the clinic." |
|
|
return to message board, top of board |
